SCHEMBL6332011

SCHEMBL6332011

O=Cc1ccc(OCCCN2CCCCC2)c(F)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.52
ALDH1A1 P00352 5/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
LTA4H P09960 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.47
ACHE P22303 3/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
PKM P14618 1/20 0.46
HRH1 P35367 2/20 0.46
HRH3 Q9Y5N1 2/20 0.46
KCNH2 Q12809 1/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4125248 0.99 KDM4E (0.53) KDM4EALDH1A1MEN1KMT2ACYP2D6
SCHEMBL8891214 0.93 LTA4H (0.60) KDM4EALDH1A1MEN1KMT2ACYP2D6
SCHEMBL3428960 0.88 ALDH1A1 (0.49) KDM4EALDH1A1MEN1KMT2ACYP2D6
SCHEMBL4122703 0.88 KDM4E (0.64) KDM4EALDH1A1CYP2D6CYP2C19CYP1A2
SCHEMBL30462820 0.83 ACHE (0.65) KDM4EACHEBCHE
SCHEMBL29038401 0.83 ACHE (0.65) KDM4EACHEBCHE
SCHEMBL29038405 0.83 ACHE (0.59) KDM4EALDH1A1SMN1; SMN2ACHEBCHE
SCHEMBL29038429 0.82 FDPS (0.67) KDM4ESMN1; SMN2ACHEBCHE
SCHEMBL29038447 0.82 ACHE (0.58) KDM4EALDH1A1SMN1; SMN2ACHEBCHE
SCHEMBL30462827 0.82 FDPS (0.67) KDM4ESMN1; SMN2ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABOTT LABORATORIES 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R KDM4E 2305/4885ALDH1A1 1308/4885MEN1 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.